Doctors Note Logo

Published on: 3/12/2026

Still Depressed After Treatment? Why Novel Antidepressants Are the New Science of Relief

If standard antidepressants have not helped, newer options like esketamine or ketamine, and postpartum-specific drugs such as brexanolone and zuranolone, target glutamate to enhance neuroplasticity and can bring relief within hours to days for some people, though not everyone responds.

There are several factors to consider, including eligibility, benefits and risks, in-clinic monitoring, costs and insurance, maintenance plans, and how therapy and lifestyle fit in; see the complete details below to guide your next steps and understand when to seek urgent care.

answer background

Explanation

Still Depressed After Treatment? Why Novel Antidepressants Are the New Science of Relief

If you've taken antidepressants and still feel depressed, you are not alone.

Major depressive disorder (MDD) is one of the most common medical conditions worldwide. While traditional antidepressants help many people, up to one-third of patients do not experience full relief after trying at least one medication. This is often called treatment-resistant depression.

The good news? Mental health science has advanced significantly in recent years. A new generation of novel antidepressants is changing how we understand — and treat — depression.

Let's walk through what that means for you.


Why Traditional Antidepressants Don't Work for Everyone

Most older antidepressants — such as SSRIs (like sertraline or fluoxetine) and SNRIs (like venlafaxine) — work by increasing levels of brain chemicals such as serotonin and norepinephrine.

They can be highly effective. But they have limitations:

  • They may take 4–8 weeks to show improvement.
  • Some people experience partial relief, not full recovery.
  • Side effects like weight gain, sexual dysfunction, or fatigue can lead people to stop treatment.
  • For some individuals, symptoms persist despite multiple medication trials.

Depression is not caused by just one chemical imbalance. It involves complex interactions between:

  • Brain circuits
  • Stress hormones
  • Inflammation
  • Glutamate signaling
  • Neuroplasticity (the brain's ability to adapt and form new connections)

That's where novel antidepressants come in.


What Are Novel Antidepressants?

Novel antidepressants are newer treatments that target different biological pathways than traditional medications. Instead of focusing only on serotonin, they act on other brain systems involved in mood regulation.

The most researched and clinically used novel antidepressants include:

  • Esketamine (Spravato®) – A nasal spray derived from ketamine
  • Ketamine (IV infusion) – Used off-label in medical settings
  • Brexanolone (for postpartum depression)
  • Zuranolone – An oral medication recently approved for postpartum depression
  • Investigational drugs targeting glutamate and neuroplasticity pathways

These medications represent a shift in how we treat depression — from slowly adjusting serotonin to rapidly restoring brain communication.


How Novel Antidepressants Work Differently

1. Targeting Glutamate Instead of Serotonin

Esketamine and ketamine act on the NMDA receptor, which is part of the glutamate system — the brain's main excitatory network.

Research shows that depression may involve disrupted communication between brain cells. Glutamate-based treatments appear to:

  • Rapidly increase synaptic connections
  • Enhance neuroplasticity
  • Restore communication in mood-regulating circuits

Some patients experience improvement within hours to days, rather than weeks.


2. Promoting Brain Repair

Chronic stress and depression can shrink or weaken certain brain regions, including the hippocampus and prefrontal cortex.

Novel antidepressants may:

  • Increase brain-derived neurotrophic factor (BDNF)
  • Stimulate growth of new neural connections
  • Improve resilience against future stress

This represents a biological "reset" rather than a slow chemical adjustment.


3. Acting Quickly in Crisis Situations

One of the most important developments is the rapid reduction of suicidal thoughts in some patients treated with esketamine.

This does not mean it replaces emergency care. But in controlled clinical settings, it has shown meaningful benefit for individuals in severe depressive episodes.

If you are experiencing thoughts of self-harm, that is urgent and requires immediate medical attention.


Who Might Benefit from Novel Antidepressants?

You may want to speak with a doctor about novel antidepressants if:

  • You've tried two or more antidepressants without adequate relief
  • Your depression returns quickly after stopping medication
  • Side effects from standard medications are intolerable
  • You have severe depression with suicidal thoughts
  • You have postpartum depression

These treatments are typically used under psychiatric supervision and may require monitoring in a certified clinic.


What the Evidence Says

Clinical trials published in peer-reviewed journals show that:

  • Esketamine combined with an oral antidepressant significantly improves symptoms in treatment-resistant depression.
  • Some patients experience meaningful symptom reduction within 24–48 hours.
  • Postpartum depression treatments like brexanolone and zuranolone can reduce severe symptoms within days.

However:

  • Not everyone responds.
  • Effects may require maintenance dosing.
  • These medications can be expensive and may require insurance authorization.

They are not miracle cures — but they are real, evidence-based advances.


Are Novel Antidepressants Safe?

All medications carry risks. That includes novel antidepressants.

Common considerations include:

  • Temporary dissociation (feeling detached from reality) with esketamine
  • Blood pressure increases
  • Sedation
  • Nausea
  • Need for in-clinic monitoring after dosing

Because of potential side effects, esketamine is administered in a healthcare setting under supervision.

Your doctor will assess:

  • Medical history
  • Substance use history
  • Cardiovascular health
  • Pregnancy status
  • Current medications

Safety always comes first.


Depression Is More Than Medication

Even the most advanced novel antidepressants work best as part of a broader treatment plan.

Comprehensive care may include:

  • Cognitive behavioral therapy (CBT)
  • Trauma-informed therapy
  • Sleep optimization
  • Regular physical activity
  • Social support
  • Nutritional support
  • Management of underlying medical issues (thyroid disorders, anemia, chronic pain)

Medication can open the door. Therapy and lifestyle help keep it open.


When to Reassess Your Symptoms

If you're unsure whether what you're experiencing qualifies as ongoing depression or need clarity on the severity of your symptoms, you can take this free AI-powered Depression symptom checker to better understand your condition and prepare meaningful questions before your next doctor's visit.

Self-assessment tools are not diagnostic — but they can clarify patterns and next steps.


What to Ask Your Doctor

If you're still depressed after treatment, consider asking:

  • Do I meet criteria for treatment-resistant depression?
  • Am I a candidate for novel antidepressants?
  • What are the risks and benefits in my case?
  • How quickly might I see improvement?
  • Will I need ongoing maintenance treatment?
  • How will we monitor side effects?

Bring a list of previous medications you've tried, including dose and duration. That information helps guide next steps.


A Balanced Perspective

It's important to be realistic.

  • Novel antidepressants are not a cure-all.
  • They do not eliminate the need for therapy or long-term care.
  • They may not work for everyone.

But they represent the most significant advancement in depression treatment in decades.

For people who have felt stuck, hopeless, or exhausted by repeated medication failures, they offer something powerful: another scientifically supported option.


When to Seek Immediate Help

If you experience:

  • Thoughts of harming yourself
  • Thoughts that life is not worth living
  • Severe mood swings
  • Hallucinations or confusion

You should seek urgent medical care or contact emergency services immediately.

Depression is a medical condition — not a personal weakness — and severe symptoms deserve immediate attention.


The Bottom Line

If you're still depressed after treatment, it does not mean:

  • You failed treatment
  • You are untreatable
  • Nothing will work

It may simply mean your brain requires a different biological approach.

Novel antidepressants are reshaping modern psychiatry by targeting new brain pathways, promoting neuroplasticity, and offering faster relief for some patients — especially those with treatment-resistant depression.

The next step is not to lose hope. It's to have a well-informed conversation with a qualified healthcare professional.

If your symptoms are persistent, worsening, or feel life-threatening in any way, speak to a doctor immediately.

Depression is serious — but it is also treatable. And science continues to move forward.

(References)

  • * McIntyre RS, Lépine JP, Gendarme V, Mansur RB, Lee Y. Novel Treatments for Treatment-Resistant Depression. J Clin Psychiatry. 2021 Apr 13;82(3):E1-E1. doi: 10.4088/JCP.21NR03781. PMID: 33857321.

  • * Micale V, Mazzon E, De Salve A, Grasso M. Emerging rapid-acting antidepressants: novel mechanisms and clinical implications. Front Neurosci. 2023 Feb 27;17:1140924. doi: 10.3389/fnins.2023.1140924. PMID: 36923485; PMCID: PMC10005740.

  • * Sawiak A, Włodarczyk A, Wasilewski D, Mierzejewski P. Ketamine and Esketamine in the Treatment of Depression: A Literature Review. J Clin Med. 2023 Nov 28;12(23):7404. doi: 10.3390/jcm12237404. PMID: 38068595; PMCID: PMC10707767.

  • * Sanacora G, Abdallah CG, Krystal JH. Psychedelics in the treatment of mood disorders: The next generation of antidepressants? Nat Rev Drug Discov. 2022 Dec;21(12):883-884. doi: 10.1038/d41573-022-00179-8. PMID: 36284145.

  • * Kularathna S, Siskind D, Hides L, Holgate G, Parker G. Novel therapeutic strategies for treating depression: An update. Aust N Z J Psychiatry. 2023 Oct;57(10):1136-1153. doi: 10.1177/00048674231189785. Epub 2023 Jul 26. PMID: 37492167.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Depression

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.